Hemodynamic indices in pulmonary hypertension: a narrative review - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Objective Pulmonary hypertension (PH) is a chronic and progressive pulmonary vascular
disease resulting in symptoms such as shortness of breath and fatigue and leading to death …

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by
endothelial dysfunction and vascular remodeling. Despite significant advancement in our …

Portopulmonary hypertension (PoPH) is a type of pulmonary vascular disease due to portal
hypertension that exhibits high morbidity and mortality. The mechanisms driving disease are …

Background: Pulmonary hypertension arise from an increase in resistance within the
pulmonary vasculature, leading to consequences such as hypoxia, hypoxemia, and right …

Over a third of patients surviving acute pulmonary embolism (PE) will experience long-term
cardiopulmonary limitations. Persistent thrombi, impaired gas exchange, and altered …

Patients with chronic congestive heart failure belong to a population with reduced quality of
life, poor functional class, and increased risk of mortality and morbidity. In these patients …

Eisenmenger syndrome is the most severe and extreme phenotype of pulmonary arterial
hypertension associated with congenital heart disease. A large nonrestrictive systemic left-to …

Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure
(PAP). Although rightheart catheterization is the gold standard method for the diagnosis of …

Pulmonary hypertension (PH) is a group of syndromes characterized by irreversible vascular
remodeling and persistent elevation of pulmonary vascular resistance and pressure, leading …